Mastering Pulse Structure: How VSP (Variable Sequential Pulsing) in DermaV Redefines Safety in Complex Vascular Cases

Introduction: Beyond the Constraints of Traditional Pulse Duration

In the realm of vascular dermatology, experts recognize that “Pulse Duration” is the critical variable balancing clinical efficacy and safety. For a redness treatment laser or any facial laser device targeting vascular lesions, the goal is straightforward: deliver enough thermal energy to coagulate the vessel without damaging the surrounding tissue.

However, clinical reality is rarely simple. Physicians frequently encounter “difficult cases”—resistant Port Wine Stains (PWS), thick reticular veins, or vascular lesions in patients with darker skin phototypes (Fitzpatrick IV-V). In these scenarios, the traditional approach of simply extending the pulse duration to increase depth often backfires. A longer continuous pulse can lead to excessive heat diffusion into the epidermis, significantly increasing the risk of burns or Post-Inflammatory Hyperpigmentation (PIH).

This is where DermaV‘s VSP (Variable Sequential Pulsing) technology becomes a game-changer. This article provides a technical deep dive into how VSP allows physicians to engineer the laser pulse structure, utilizing micro-pulses to optimize safety and outcomes in the most challenging vascular cases.

1. The Physics of VSP: Micro-pulses and Thermal Relaxation

VSP is not merely a setting; it is a re-engineering of light delivery.

Unlike a standard redness treatment laser that emits a single, continuous long pulse, DermaV with VSP technology enables the physician to fragment that energy into a “Pulse Train” consisting of multiple Micro-pulses. This structure is defined by three controllable parameters:

1. Micro-pulses: Short, high-intensity bursts of energy.
2. Delay Time (Inter-pulse Interval): The cooling period between bursts.
3. Total Fluence: The cumulative energy delivered.

The Mechanism of Action:

VSP exploits the differential Thermal Relaxation Time (TRT) between the target (blood vessels) and the non-target (epidermis).

• The Epidermis: Being thin, it has a very short TRT (cools down rapidly).
• The Vessel: Being larger, it has a longer TRT (retains heat longer).

When DermaV fires a micro-pulse, both the skin and the vessel heat up. During the programmed “Delay Time,” the epidermis rapidly dissipates its heat, returning to a safe temperature. However, the vessel, due to its longer TRT, retains a significant portion of that heat. When the next micro-pulse arrives, the vessel’s temperature climbs stepwise (additive heating), while the epidermis is spared from cumulative thermal damage.

2. Clinical Applications in “Complex Cases”

The ability to customize pulse structure via VSP transforms DermaV into a highly versatile facial laser device, capable of managing conditions that traditional lasers struggle to treat safely.

Scenario A: Large, Resistant Vessels (e.g., Nasal Alar or Reticular Veins)

• The Challenge: Thick vessels require high total fluence to achieve coagulation. A standard single pulse delivering this much energy would likely cause “bulk heating” severe enough to burn the skin before the vessel closes.
• The DermaV Solution: By using VSP, a physician can deliver a high total fluence broken into safe packets. The delay intervals protect the epidermis, while the cumulative heat inside the large vessel reaches the coagulation threshold. This allows for the effective closure of large vessels without compromising skin integrity.

Scenario B: Darker Skin Phototypes (Fitzpatrick IV-V)

• The Challenge: In Asian or darker skin tones, epidermal melanin acts as a competing chromophore, absorbing the redness treatment laser energy meant for hemoglobin. This competition creates a high risk of burns and PIH.
• The DermaV Solution: VSP is critical here. “Delay Time” effectively gives the melanin-rich epidermis time to “breathe” and cool down between energy strikes. This allows DermaV to deliver therapeutic energy levels to the underlying vessels while minimizing the peak temperature of the epidermis, making it a safer option for treating vascular issues in darker skin.

Scenario C: Delicate Rosacea and Diffuse Redness

• The Challenge: Rosacea-prone skin is often hyper-reactive. Aggressive heating can trigger a rebound effect or worsening inflammation.
• The DermaV Solution: Physicians can utilize VSP to deliver “Gentle Heating.” By adjusting the micro-pulse structure, DermaV can slowly elevate the vessel temperature to the point of closure without causing the sudden thermal shock that triggers inflammation, ensuring a smoother recovery for sensitive patients.

3. Precision and Control: The B2B Value of VSP

For clinics, investing in a facial laser device equipped with VSP technology is an investment in “Safety” and “Expanded Indications.”

DermaV empowers physicians to move beyond fixed presets. It offers the precision of a scalpel in the form of light. The ability to manipulate the pulse train allows for the customized management of diverse vascular pathologies—from superficial redness treatment laser procedures to complex, deep-seated malformations.

Clinical evidence suggests that sequential pulsing strategies (the core of VSP) significantly improve the clearance rates of resistant vascular lesions compared to single-pulse treatments, as they allow for higher total energy delivery with reduced epidermal injury [1].

DermaV – Engineering Safer Outcomes

VSP (Variable Sequential Pulsing) technology proves that DermaV is more than just another facial laser device; it is a sophisticated tool designed with a deep understanding of laser physics and tissue interaction.

For clinics aiming to treat a broader demographic—including those with darker skin or complex vascular conditions—DermaV offers the necessary control. The capability to fine-tune micro-pulses ensures that physicians can tackle difficult cases with confidence, delivering clear results while prioritizing patient safety. This technological advantage is a key differentiator for any modern aesthetic practice.

References:

1. Tanghetti E, Sherr E. Treatment of telangiectasia using a new 532 nm laser with multipulse technology. J Drugs Dermatol. 2013.

Dierickx CC, Casparian JM, Venugopalan V, Farinelli WA, Anderson RR. Thermal relaxation of port-wine stain vessels probed in vivo: the need for 1-10-millisecond laser pulse duration. J Invest Dermatol. 1995. (Foundational concept for variable pulsing needs).